The global Artificial Intelligence Drug Development market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Artificial Intelligence Drug Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug Development. This report contains market size and forecasts of Artificial Intelligence Drug Development in global, including the following market information:
Global Artificial Intelligence Drug Development market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Artificial Intelligence Drug Development companies in 2024 (%)
Total Market by Segment:
Global Artificial Intelligence Drug Development market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Artificial Intelligence Drug Development market segment percentages, by Type, 2024 (%)
Drug Design
Drug Synthesis
Other
Global Artificial Intelligence Drug Development market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Artificial Intelligence Drug Development market segment percentages, by Application, 2024 (%)
Tumor
Nervous System
Other
Global Artificial Intelligence Drug Development market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Artificial Intelligence Drug Development market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence Drug Development revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Artificial Intelligence Drug Development revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg?Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artificial Intelligence Drug Development, market overview.
Chapter 2: Global Artificial Intelligence Drug Development market size in revenue.
Chapter 3: Detailed analysis of Artificial Intelligence Drug Development company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Intelligence Drug Development in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug Development Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Artificial Intelligence Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug Development Overall Market Size
2.1 Global Artificial Intelligence Drug Development Market Size: 2024 VS 2032
2.2 Global Artificial Intelligence Drug Development Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug Development Players in Global Market
3.2 Top Global Artificial Intelligence Drug Development Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug Development Companies in Global Market, by Revenue in 2024
3.5 Global Companies Artificial Intelligence Drug Development Product Type
3.6 Tier 1, Tier 2, and Tier 3 Artificial Intelligence Drug Development Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Artificial Intelligence Drug Development Market Size Markets, 2024 & 2032
4.1.2 Drug Design
4.1.3 Drug Synthesis
4.1.4 Other
4.2 Segmentation by Type - Global Artificial Intelligence Drug Development Revenue & Forecasts
4.2.1 Segmentation by Type - Global Artificial Intelligence Drug Development Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Artificial Intelligence Drug Development Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Artificial Intelligence Drug Development Market Size, 2024 & 2032
5.1.2 Tumor
5.1.3 Nervous System
5.1.4 Other
5.2 Segmentation by Application - Global Artificial Intelligence Drug Development Revenue & Forecasts
5.2.1 Segmentation by Application - Global Artificial Intelligence Drug Development Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Artificial Intelligence Drug Development Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug Development Market Size, 2024 & 2032
6.2 By Region - Global Artificial Intelligence Drug Development Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug Development Revenue, 2020-2025
6.2.2 By Region - Global Artificial Intelligence Drug Development Revenue, 2026-2032
6.2.3 By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug Development Revenue, 2020-2032
6.3.2 United States Artificial Intelligence Drug Development Market Size, 2020-2032
6.3.3 Canada Artificial Intelligence Drug Development Market Size, 2020-2032
6.3.4 Mexico Artificial Intelligence Drug Development Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug Development Revenue, 2020-2032
6.4.2 Germany Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.3 France Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.4 U.K. Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.5 Italy Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.6 Russia Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.7 Nordic Countries Artificial Intelligence Drug Development Market Size, 2020-2032
6.4.8 Benelux Artificial Intelligence Drug Development Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug Development Revenue, 2020-2032
6.5.2 China Artificial Intelligence Drug Development Market Size, 2020-2032
6.5.3 Japan Artificial Intelligence Drug Development Market Size, 2020-2032
6.5.4 South Korea Artificial Intelligence Drug Development Market Size, 2020-2032
6.5.5 Southeast Asia Artificial Intelligence Drug Development Market Size, 2020-2032
6.5.6 India Artificial Intelligence Drug Development Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug Development Revenue, 2020-2032
6.6.2 Brazil Artificial Intelligence Drug Development Market Size, 2020-2032
6.6.3 Argentina Artificial Intelligence Drug Development Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, 2020-2032
6.7.2 Turkey Artificial Intelligence Drug Development Market Size, 2020-2032
6.7.3 Israel Artificial Intelligence Drug Development Market Size, 2020-2032
6.7.4 Saudi Arabia Artificial Intelligence Drug Development Market Size, 2020-2032
6.7.5 UAE Artificial Intelligence Drug Development Market Size, 2020-2032
7 Companies Profiles
7.1 Insilico Medicine
7.1.1 Insilico Medicine Corporate Summary
7.1.2 Insilico Medicine Business Overview
7.1.3 Insilico Medicine Artificial Intelligence Drug Development Major Product Offerings
7.1.4 Insilico Medicine Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.1.5 Insilico Medicine Key News & Latest Developments
7.2 Cyclica
7.2.1 Cyclica Corporate Summary
7.2.2 Cyclica Business Overview
7.2.3 Cyclica Artificial Intelligence Drug Development Major Product Offerings
7.2.4 Cyclica Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.2.5 Cyclica Key News & Latest Developments
7.3 XtalPi Inc.
7.3.1 XtalPi Inc. Corporate Summary
7.3.2 XtalPi Inc. Business Overview
7.3.3 XtalPi Inc. Artificial Intelligence Drug Development Major Product Offerings
7.3.4 XtalPi Inc. Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.3.5 XtalPi Inc. Key News & Latest Developments
7.4 Exscientia Limited
7.4.1 Exscientia Limited Corporate Summary
7.4.2 Exscientia Limited Business Overview
7.4.3 Exscientia Limited Artificial Intelligence Drug Development Major Product Offerings
7.4.4 Exscientia Limited Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.4.5 Exscientia Limited Key News & Latest Developments
7.5 AiCure, LLC
7.5.1 AiCure, LLC Corporate Summary
7.5.2 AiCure, LLC Business Overview
7.5.3 AiCure, LLC Artificial Intelligence Drug Development Major Product Offerings
7.5.4 AiCure, LLC Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.5.5 AiCure, LLC Key News & Latest Developments
7.6 Atomwise
7.6.1 Atomwise Corporate Summary
7.6.2 Atomwise Business Overview
7.6.3 Atomwise Artificial Intelligence Drug Development Major Product Offerings
7.6.4 Atomwise Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.6.5 Atomwise Key News & Latest Developments
7.7 Biovista Inc.
7.7.1 Biovista Inc. Corporate Summary
7.7.2 Biovista Inc. Business Overview
7.7.3 Biovista Inc. Artificial Intelligence Drug Development Major Product Offerings
7.7.4 Biovista Inc. Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.7.5 Biovista Inc. Key News & Latest Developments
7.8 Breg?Inc.
7.8.1 Breg?Inc. Corporate Summary
7.8.2 Breg?Inc. Business Overview
7.8.3 Breg?Inc. Artificial Intelligence Drug Development Major Product Offerings
7.8.4 Breg?Inc. Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.8.5 Breg?Inc. Key News & Latest Developments
7.9 Numerate
7.9.1 Numerate Corporate Summary
7.9.2 Numerate Business Overview
7.9.3 Numerate Artificial Intelligence Drug Development Major Product Offerings
7.9.4 Numerate Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.9.5 Numerate Key News & Latest Developments
7.10 Cloud Pharmaceuticals
7.10.1 Cloud Pharmaceuticals Corporate Summary
7.10.2 Cloud Pharmaceuticals Business Overview
7.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Major Product Offerings
7.10.4 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.10.5 Cloud Pharmaceuticals Key News & Latest Developments
7.11 IBM
7.11.1 IBM Corporate Summary
7.11.2 IBM Business Overview
7.11.3 IBM Artificial Intelligence Drug Development Major Product Offerings
7.11.4 IBM Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.11.5 IBM Key News & Latest Developments
7.12 NuMedii
7.12.1 NuMedii Corporate Summary
7.12.2 NuMedii Business Overview
7.12.3 NuMedii Artificial Intelligence Drug Development Major Product Offerings
7.12.4 NuMedii Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.12.5 NuMedii Key News & Latest Developments
7.13 BenevolentAI
7.13.1 BenevolentAI Corporate Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI Artificial Intelligence Drug Development Major Product Offerings
7.13.4 BenevolentAI Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.13.5 BenevolentAI Key News & Latest Developments
7.14 Lam Therapeutics
7.14.1 Lam Therapeutics Corporate Summary
7.14.2 Lam Therapeutics Business Overview
7.14.3 Lam Therapeutics Artificial Intelligence Drug Development Major Product Offerings
7.14.4 Lam Therapeutics Artificial Intelligence Drug Development Revenue in Global Market (2020-2025)
7.14.5 Lam Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Artificial Intelligence Drug Development Market Opportunities & Trends in Global Market
Table 2. Artificial Intelligence Drug Development Market Drivers in Global Market
Table 3. Artificial Intelligence Drug Development Market Restraints in Global Market
Table 4. Key Players of Artificial Intelligence Drug Development in Global Market
Table 5. Top Artificial Intelligence Drug Development Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Artificial Intelligence Drug Development Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Artificial Intelligence Drug Development Revenue Share by Companies, 2020-2025
Table 8. Global Companies Artificial Intelligence Drug Development Product Type
Table 9. List of Global Tier 1 Artificial Intelligence Drug Development Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Artificial Intelligence Drug Development Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Artificial Intelligence Drug Development Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, (US$, Mn), 2026-2032
Table 30. Insilico Medicine Corporate Summary
Table 31. Insilico Medicine Artificial Intelligence Drug Development Product Offerings
Table 32. Insilico Medicine Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 33. Insilico Medicine Key News & Latest Developments
Table 34. Cyclica Corporate Summary
Table 35. Cyclica Artificial Intelligence Drug Development Product Offerings
Table 36. Cyclica Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 37. Cyclica Key News & Latest Developments
Table 38. XtalPi Inc. Corporate Summary
Table 39. XtalPi Inc. Artificial Intelligence Drug Development Product Offerings
Table 40. XtalPi Inc. Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 41. XtalPi Inc. Key News & Latest Developments
Table 42. Exscientia Limited Corporate Summary
Table 43. Exscientia Limited Artificial Intelligence Drug Development Product Offerings
Table 44. Exscientia Limited Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 45. Exscientia Limited Key News & Latest Developments
Table 46. AiCure, LLC Corporate Summary
Table 47. AiCure, LLC Artificial Intelligence Drug Development Product Offerings
Table 48. AiCure, LLC Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 49. AiCure, LLC Key News & Latest Developments
Table 50. Atomwise Corporate Summary
Table 51. Atomwise Artificial Intelligence Drug Development Product Offerings
Table 52. Atomwise Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 53. Atomwise Key News & Latest Developments
Table 54. Biovista Inc. Corporate Summary
Table 55. Biovista Inc. Artificial Intelligence Drug Development Product Offerings
Table 56. Biovista Inc. Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 57. Biovista Inc. Key News & Latest Developments
Table 58. Breg?Inc. Corporate Summary
Table 59. Breg?Inc. Artificial Intelligence Drug Development Product Offerings
Table 60. Breg?Inc. Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 61. Breg?Inc. Key News & Latest Developments
Table 62. Numerate Corporate Summary
Table 63. Numerate Artificial Intelligence Drug Development Product Offerings
Table 64. Numerate Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 65. Numerate Key News & Latest Developments
Table 66. Cloud Pharmaceuticals Corporate Summary
Table 67. Cloud Pharmaceuticals Artificial Intelligence Drug Development Product Offerings
Table 68. Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 69. Cloud Pharmaceuticals Key News & Latest Developments
Table 70. IBM Corporate Summary
Table 71. IBM Artificial Intelligence Drug Development Product Offerings
Table 72. IBM Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 73. IBM Key News & Latest Developments
Table 74. NuMedii Corporate Summary
Table 75. NuMedii Artificial Intelligence Drug Development Product Offerings
Table 76. NuMedii Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 77. NuMedii Key News & Latest Developments
Table 78. BenevolentAI Corporate Summary
Table 79. BenevolentAI Artificial Intelligence Drug Development Product Offerings
Table 80. BenevolentAI Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 81. BenevolentAI Key News & Latest Developments
Table 82. Lam Therapeutics Corporate Summary
Table 83. Lam Therapeutics Artificial Intelligence Drug Development Product Offerings
Table 84. Lam Therapeutics Artificial Intelligence Drug Development Revenue (US$, Mn) & (2020-2025)
Table 85. Lam Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Artificial Intelligence Drug Development Product Picture
Figure 2. Artificial Intelligence Drug Development Segment by Type in 2024
Figure 3. Artificial Intelligence Drug Development Segment by Application in 2024
Figure 4. Global Artificial Intelligence Drug Development Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Artificial Intelligence Drug Development Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Artificial Intelligence Drug Development Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Artificial Intelligence Drug Development Revenue in 2024
Figure 9. Segmentation by Type � Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Artificial Intelligence Drug Development Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 13. By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 14. By Country - North America Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 15. United States Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 19. Germany Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 20. France Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 27. China Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 31. India Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 33. Brazil Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue Market Share, 2020-2032
Figure 36. Turkey Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Artificial Intelligence Drug Development Revenue, (US$, Mn), 2020-2032
Figure 40. Insilico Medicine Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Cyclica Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. XtalPi Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Exscientia Limited Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. AiCure, LLC Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Atomwise Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Biovista Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Breg?Inc. Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Numerate Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. IBM Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. NuMedii Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. BenevolentAI Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Lam Therapeutics Artificial Intelligence Drug Development Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
